Nyxoah SA Cash on Hand 2021-2024 | NYXH
Nyxoah SA cash on hand from 2021 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
| Nyxoah SA Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2023 | $63 |
| 2022 | $100 |
| 2021 | $160 |
| 2020 | $105 |
| Nyxoah SA Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2024-09-30 | $78 |
| 2024-06-30 | $84 |
| 2024-03-31 | $48 |
| 2023-12-31 | $63 |
| 2023-09-30 | $79 |
| 2023-06-30 | $92 |
| 2023-03-31 | $103 |
| 2022-12-31 | $100 |
| 2022-09-30 | $116 |
| 2022-06-30 | $131 |
| 2022-03-31 | $143 |
| 2021-12-31 | |
| 2021-03-31 | $104 |
| 2020-12-31 | $105 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.352B | $0.005B |
| Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium. | |||